161 related articles for article (PubMed ID: 22429966)
21. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
[TBL] [Abstract][Full Text] [Related]
22. Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma.
Dang TN; Tiongco RP; Brown LM; Taylor JL; Lyons JM; Lau FH; Floyd ZE
BMC Cancer; 2022 Mar; 22(1):300. PubMed ID: 35313831
[TBL] [Abstract][Full Text] [Related]
23. Perilipin 1 Expression Differentiates Liposarcoma from Other Types of Soft Tissue Sarcoma.
Straub BK; Witzel HR; Pawella LM; Renner M; Eiteneuer E; Hashani M; Schirmacher P; Roth W; Mechtersheimer G
Am J Pathol; 2019 Aug; 189(8):1547-1558. PubMed ID: 31125552
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic and molecular cytogenetic findings in dedifferentiated liposarcoma with neural-like whorling pattern and metaplastic bone formation.
Macarenco RS; Erickson-Johnson M; Wang X; Jenkins RB; Nascimento AG; Oliveira AM
Cancer Genet Cytogenet; 2007 Jan; 172(2):147-50. PubMed ID: 17213023
[TBL] [Abstract][Full Text] [Related]
25. Well-differentiated liposarcoma (atypical lipomatous tumors).
Laurino L; Furlanetto A; Orvieto E; Dei Tos AP
Semin Diagn Pathol; 2001 Nov; 18(4):258-62. PubMed ID: 11757865
[TBL] [Abstract][Full Text] [Related]
26. Let-7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data.
Bianchini L; Saâda E; Gjernes E; Marty M; Haudebourg J; Birtwisle-Peyrottes I; Keslair F; Chignon-Sicard B; Chamorey E; Pedeutour F
Genes Chromosomes Cancer; 2011 Jun; 50(6):442-55. PubMed ID: 21412931
[TBL] [Abstract][Full Text] [Related]
27. Enolase 1 and calreticulin regulate the differentiation and function of mouse mast cells.
Ryu SY; Hong GU; Kim DY; Ro JY
Cell Signal; 2012 Jan; 24(1):60-70. PubMed ID: 21803152
[TBL] [Abstract][Full Text] [Related]
28. [Molecular diagnosis of liposarcomas: identification of the chimeric genes FUS/CHOP and EWS/CHOP].
Kekeeva TV; Riazantseva AA; Anreeva IuIu; Zavalishina LE; Babenko OV; Zaletaev DV; Petrov AN; Frank GA
Arkh Patol; 2009; 71(5):32-5. PubMed ID: 19938700
[TBL] [Abstract][Full Text] [Related]
29. Primary mediastinal liposarcoma: clinicopathologic analysis of 24 cases.
Hahn HP; Fletcher CD
Am J Surg Pathol; 2007 Dec; 31(12):1868-74. PubMed ID: 18043041
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of a novel dedifferentiated liposarcoma cell line, NDDLS-1.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Hirose T; Endo N
Pathol Int; 2011 Aug; 61(8):461-8. PubMed ID: 21790860
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is highly expressed in liposarcoma and promotes migration and proliferation.
Wagner KD; Benchetrit M; Bianchini L; Michiels JF; Wagner N
J Pathol; 2011 Aug; 224(4):575-88. PubMed ID: 21598253
[TBL] [Abstract][Full Text] [Related]
32. Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1.
Kanojia D; Kirtonia A; Srujana NSV; Jeevanandan SP; Shyamsunder P; Sampath SS; Dakle P; Mayakonda A; Kaur H; Yanyi J; Koeffler HP; Garg M
Pharmacol Res; 2022 Nov; 185():106462. PubMed ID: 36167276
[TBL] [Abstract][Full Text] [Related]
33. The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas.
Hemminger JA; Ewart Toland A; Scharschmidt TJ; Mayerson JL; Kraybill WG; Guttridge DC; Iwenofu OH
Mod Pathol; 2013 Feb; 26(2):282-8. PubMed ID: 22936067
[TBL] [Abstract][Full Text] [Related]
34. Liposarcoma: new entities and evolving concepts.
Dei Tos AP
Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304
[TBL] [Abstract][Full Text] [Related]
35. ZIC1 overexpression is oncogenic in liposarcoma.
Brill E; Gobble R; Angeles C; Lagos-Quintana M; Crago A; Laxa B; Decarolis P; Zhang L; Antonescu C; Socci ND; Taylor BS; Sander C; Koff A; Singer S
Cancer Res; 2010 Sep; 70(17):6891-901. PubMed ID: 20713527
[TBL] [Abstract][Full Text] [Related]
36. Dedifferentiated liposarcoma of the pyriform sinus: report of a case and review of the literature.
González-Lois C; Ibarrola C; Ballestín C; Martánez-Tello FJ
Int J Surg Pathol; 2002 Jan; 10(1):75-9. PubMed ID: 11927975
[TBL] [Abstract][Full Text] [Related]
37. Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.
Ugras S; Brill E; Jacobsen A; Hafner M; Socci ND; Decarolis PL; Khanin R; O'Connor R; Mihailovic A; Taylor BS; Sheridan R; Gimble JM; Viale A; Crago A; Antonescu CR; Sander C; Tuschl T; Singer S
Cancer Res; 2011 Sep; 71(17):5659-69. PubMed ID: 21693658
[TBL] [Abstract][Full Text] [Related]
38. S-100 protein distribution in liposarcoma. An immunoperoxidase study with special reference to the distinction of liposarcoma from myxoid malignant fibrous histiocytoma.
Hashimoto H; Daimaru Y; Enjoji M
Virchows Arch A Pathol Anat Histopathol; 1984; 405(1):1-10. PubMed ID: 6095521
[TBL] [Abstract][Full Text] [Related]
39. The ultrastructure of liposarcomas with attention to "dedifferentiation".
Chorneyko K
Ultrastruct Pathol; 1997; 21(6):545-57. PubMed ID: 9355237
[TBL] [Abstract][Full Text] [Related]
40. Managing Liposarcomas: Cutting Through the Fat.
Manji GA; Schwartz GK
J Oncol Pract; 2016 Mar; 12(3):221-7. PubMed ID: 26962163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
